151 related articles for article (PubMed ID: 11607815)
21. Expression of the TCL1 gene at 14q32 in B-cell malignancies but not in adult T-cell leukemia.
Takizawa J; Suzuki R; Kuroda H; Utsunomiya A; Kagami Y; Joh T; Aizawa Y; Ueda R; Seto M
Jpn J Cancer Res; 1998 Jul; 89(7):712-8. PubMed ID: 9738977
[TBL] [Abstract][Full Text] [Related]
22. Identification of the TCL1 gene involved in T-cell malignancies.
Virgilio L; Narducci MG; Isobe M; Billips LG; Cooper MD; Croce CM; Russo G
Proc Natl Acad Sci U S A; 1994 Dec; 91(26):12530-4. PubMed ID: 7809072
[TBL] [Abstract][Full Text] [Related]
23. The proto-oncogene BCL-6 in normal and malignant B cell development.
Niu H
Hematol Oncol; 2002 Dec; 20(4):155-66. PubMed ID: 12469325
[TBL] [Abstract][Full Text] [Related]
24. TCL1 oncogene activation in preleukemic T cells from a case of ataxia-telangiectasia.
Narducci MG; Virgilio L; Isobe M; Stoppacciaro A; Elli R; Fiorilli M; Carbonari M; Antonelli A; Chessa L; Croce CM; Russo G
Blood; 1995 Sep; 86(6):2358-64. PubMed ID: 7662982
[TBL] [Abstract][Full Text] [Related]
25. Characterization and localization of the TCL-1 oncogene product.
Fu TB; Virgilio L; Narducci MG; Facchiano A; Russo G; Croce CM
Cancer Res; 1994 Dec; 54(24):6297-301. PubMed ID: 7987816
[TBL] [Abstract][Full Text] [Related]
26. A novel gene, FGA7, is fused to RUNX1/AML1 in a t(4;21)(q28;q22) in a patient with T-cell acute lymphoblastic leukemia.
Mikhail FM; Coignet L; Hatem N; Mourad ZI; Farawela HM; El Kaffash DM; Farahat N; Nucifora G
Genes Chromosomes Cancer; 2004 Feb; 39(2):110-8. PubMed ID: 14695990
[TBL] [Abstract][Full Text] [Related]
27. Alternative translocation breakpoint cluster region 5' to BCL-6 in B-cell non-Hodgkin's lymphoma.
Butler MP; Iida S; Capello D; Rossi D; Rao PH; Nallasivam P; Louie DC; Chaganti S; Au T; Gascoyne RD; Gaidano G; Chaganti RS; Dalla-Favera R
Cancer Res; 2002 Jul; 62(14):4089-94. PubMed ID: 12124346
[TBL] [Abstract][Full Text] [Related]
28. The MTCP-1/c6.1B gene encodes for a cytoplasmic 8 kD protein overexpressed in T cell leukemia bearing a t(X;14) translocation.
Soulier J; Madani A; Cacheux V; Rosenzwajg M; Sigaux F; Stern MH
Oncogene; 1994 Dec; 9(12):3565-70. PubMed ID: 7970717
[TBL] [Abstract][Full Text] [Related]
29. The recurrent translocation t(14;20)(q32;q12) in multiple myeloma results in aberrant expression of MAFB: a molecular and genetic analysis of the chromosomal breakpoint.
Boersma-Vreugdenhil GR; Kuipers J; Van Stralen E; Peeters T; Michaux L; Hagemeijer A; Pearson PL; Clevers HC; Bast BJ
Br J Haematol; 2004 Aug; 126(3):355-63. PubMed ID: 15257707
[TBL] [Abstract][Full Text] [Related]
30. Targeting mature T cell leukemia: new understanding of molecular pathways.
Pekarsky Y; Hallas C; Croce CM
Am J Pharmacogenomics; 2003; 3(1):31-6. PubMed ID: 12562214
[TBL] [Abstract][Full Text] [Related]
31. [Searching for the disease related genes from human chromosome 14].
Isobe M
Tanpakushitsu Kakusan Koso; 2001 Dec; 46(16 Suppl):2232-5. PubMed ID: 11802372
[No Abstract] [Full Text] [Related]
32. Chromosomal imbalances in adult T-cell leukemia revealed by comparative genomic hybridization: gains at 14q32 and 2p16-22 in cell lines.
Ariyama Y; Mori T; Shinomiya T; Sakabe T; Fukuda Y; Kanamaru A; Yamada Y; Isobe M; Seto M; Nakamura Y; Inazawa J
J Hum Genet; 1999; 44(6):357-63. PubMed ID: 10570904
[TBL] [Abstract][Full Text] [Related]
33. Amplification of the TCL1 flanking region at 14q32.1 with no TCL1 gene transcription in a patient with peripheral T cell lymphoma.
Sakashita ; Kobayashi H; Satake N; Maseki N; Sakurai M; Izumo T; Isobe M; Kaneko Y
Leukemia; 1998 Jun; 12(6):970-1. PubMed ID: 9639427
[TBL] [Abstract][Full Text] [Related]
34. The gene for interleukin-21 receptor is the partner of BCL6 in t(3;16)(q27;p11), which is recurrently observed in diffuse large B-cell lymphoma.
Ueda C; Akasaka T; Kurata M; Maesako Y; Nishikori M; Ichinohasama R; Imada K; Uchiyama T; Ohno H
Oncogene; 2002 Jan; 21(3):368-76. PubMed ID: 11821949
[TBL] [Abstract][Full Text] [Related]
35. BCL11B rearrangements probably target T-cell neoplasia rather than acute myelocytic leukemia.
MacLeod RA; Nagel S; Drexler HG
Cancer Genet Cytogenet; 2004 Aug; 153(1):88-9. PubMed ID: 15325104
[No Abstract] [Full Text] [Related]
36. Distinct response in maintenance of human naive and memory B cells via IL-21 receptor and TCL1/Akt pathways.
Nagumo H; Abe J; Kano H; Taki S; Yamazaki K; Yamazaki T; Kobayashi N; Koike K; Sugane K; Saito H; Agematsu K
Cell Immunol; 2009; 256(1-2):56-63. PubMed ID: 19230867
[TBL] [Abstract][Full Text] [Related]
37. Mutation of all Runx (AML1/core) sites in the enhancer of T-lymphomagenic SL3-3 murine leukemia virus unmasks a significant potential for myeloid leukemia induction and favors enhancer evolution toward induction of other disease patterns.
Sørensen KD; Quintanilla-Martinez L; Kunder S; Schmidt J; Pedersen FS
J Virol; 2004 Dec; 78(23):13216-31. PubMed ID: 15542674
[TBL] [Abstract][Full Text] [Related]
38. Expression of TCL1 in hematologic disorders.
Roos J; Hennig I; Schwaller J; Zbären J; Dummer R; Burg G; Tobler A; Virgilio L; Croce CM; Fey MF; Borisch B
Pathobiology; 2001; 69(2):59-66. PubMed ID: 11752899
[TBL] [Abstract][Full Text] [Related]
39. The protooncogene TCL1 is an Akt kinase coactivator.
Laine J; Künstle G; Obata T; Sha M; Noguchi M
Mol Cell; 2000 Aug; 6(2):395-407. PubMed ID: 10983986
[TBL] [Abstract][Full Text] [Related]
40. Tcl1 enhances Akt kinase activity and mediates its nuclear translocation.
Pekarsky Y; Koval A; Hallas C; Bichi R; Tresini M; Malstrom S; Russo G; Tsichlis P; Croce CM
Proc Natl Acad Sci U S A; 2000 Mar; 97(7):3028-33. PubMed ID: 10716693
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
